Russian billionaire may construct largest pharma plant in Belarus

Vladimir Bryntsalov, one of Russia’s richest businessman, and the Belarusian Belbiopharm state concern, may invest up to $120 million in the construction of the largest pharmaceutical plant in Belarus. The new plant is expected to be built in 2015 on the base of a state pharmaceutical company Dialek.

Expected total production capacities of the plant were not disclosed. According to some Belarus media reports, however, the new facility will focus on the production of certain pharmaceutical drugs and antibiotics, which should replace their more expensive imported analogues.

Imports now account for 80% of market